health

dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion

Il BioeconomistaLeave a comment

dsm-firmenich, the Dutch multinational company active in nutrition, health, and beauty, sold its stake in the Feed Enzymes Alliance to its equal partner Novonesis, a global leader in biosolutions, for €1.5 billion. The dsm-firmenich activities to be sold under this transaction to Novonesis represented in 2024 approximately €300 million in total annual net sales. Novonesis will continue a long-term commercial relationship with the Animal Nutrition & Health business, for the re-sale of its feed enzymes through the Animal Nutrition & Health world-class premix network.

Continue reading →

An interview with Christophe Rupp-Dahlem: “Roquette is taking a holistic approach of bioeconomy”

Il Bioeconomista1 Comment

Christophe Rupp-Dahlem

“Roquette is taking a holistic approach of bioeconomy by integrating various applications of plant-based resources and in particular those serving Nutrition and Health markets.” Christophe Rupp-Dahlem, Head of Global Public Affairs at Roquette, talks to Il Bioeconomista. In this exclusive interview he tells us what are Roquette’s main achievements in the bioeconomy and what the next steps.

Interview by Mario Bonaccorso

Continue reading →

Royal DSM to make an equity investment in Amyris

Il BioeconomistaLeave a comment

John Melo, President & Ceo of Amyris

Amyris, Inc., the U.S. industrial bioscience company, and Koninklijke DSM N.V. (Royal DSM), the Dutch global science-based company active in health, nutrition and materials, have agreed for DSM to make an equity investment in Amyris. At the same time, the companies will enter into a development cooperation focused on products for the global health and nutrition markets (including vitamins and other nutritional ingredients).
Continue reading →